Latest Articles

Publication Date
Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis marketscreener.com

Published: March 4, 2026, 11:51 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis lelezard.com

Published: March 4, 2026, 10:17 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - Bolsamania

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis Bolsamania

Published: March 4, 2026, 7:30 a.m.
Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Cambs Times

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease Cambs Times

Published: March 4, 2026, 7 a.m.
Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease - Ely Standard

Cambridgeshire gym boss takes on daily walk to highlight ‘terrible’ disease Ely Standard

Published: March 4, 2026, 7 a.m.
Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening Nature

Published: March 3, 2026, 10:36 a.m.
Endometriosis Shuswap looking to spread the word about the disease - Castanet

Endometriosis Shuswap looking to spread the word about the disease Castanet

Published: March 3, 2026, 3 a.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Defense World

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Defense World

Published: March 2, 2026, 6:50 p.m.
ACOG Releases Updated Clinical Guidance on Endometriosis to Accelerate Diagnosis and Improve Access to... - Medical Dialogues

ACOG Releases Updated Clinical Guidance on Endometriosis to Accelerate Diagnosis and Improve Access to... Medical Dialogues

Published: March 2, 2026, 2:45 p.m.
Center for Endometriosis Care Calls for Greater Disease Support During Endometriosis Awareness Month - PR.com

Center for Endometriosis Care Calls for Greater Disease Support During Endometriosis Awareness Month PR.com

Published: March 2, 2026, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!